API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
68
PharmaCompass offers a list of Cyclobenzaprine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyclobenzaprine manufacturer or Cyclobenzaprine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyclobenzaprine manufacturer or Cyclobenzaprine supplier.
PharmaCompass also assists you with knowing the Cyclobenzaprine API Price utilized in the formulation of products. Cyclobenzaprine API Price is not always fixed or binding as the Cyclobenzaprine Price is obtained through a variety of data sources. The Cyclobenzaprine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cyclobenzaprine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyclobenzaprine HCl, including repackagers and relabelers. The FDA regulates Cyclobenzaprine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyclobenzaprine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyclobenzaprine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyclobenzaprine HCl supplier is an individual or a company that provides Cyclobenzaprine HCl active pharmaceutical ingredient (API) or Cyclobenzaprine HCl finished formulations upon request. The Cyclobenzaprine HCl suppliers may include Cyclobenzaprine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Cyclobenzaprine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cyclobenzaprine HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Cyclobenzaprine HCl active pharmaceutical ingredient (API) in detail. Different forms of Cyclobenzaprine HCl DMFs exist exist since differing nations have different regulations, such as Cyclobenzaprine HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cyclobenzaprine HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Cyclobenzaprine HCl USDMF includes data on Cyclobenzaprine HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cyclobenzaprine HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cyclobenzaprine HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cyclobenzaprine HCl Drug Master File in Japan (Cyclobenzaprine HCl JDMF) empowers Cyclobenzaprine HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cyclobenzaprine HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Cyclobenzaprine HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cyclobenzaprine HCl suppliers with JDMF on PharmaCompass.
A Cyclobenzaprine HCl written confirmation (Cyclobenzaprine HCl WC) is an official document issued by a regulatory agency to a Cyclobenzaprine HCl manufacturer, verifying that the manufacturing facility of a Cyclobenzaprine HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cyclobenzaprine HCl APIs or Cyclobenzaprine HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Cyclobenzaprine HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Cyclobenzaprine HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyclobenzaprine HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cyclobenzaprine HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cyclobenzaprine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cyclobenzaprine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyclobenzaprine HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cyclobenzaprine HCl suppliers with NDC on PharmaCompass.
Cyclobenzaprine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cyclobenzaprine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyclobenzaprine HCl GMP manufacturer or Cyclobenzaprine HCl GMP API supplier for your needs.
A Cyclobenzaprine HCl CoA (Certificate of Analysis) is a formal document that attests to Cyclobenzaprine HCl's compliance with Cyclobenzaprine HCl specifications and serves as a tool for batch-level quality control.
Cyclobenzaprine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Cyclobenzaprine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cyclobenzaprine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyclobenzaprine HCl EP), Cyclobenzaprine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyclobenzaprine HCl USP).